Another possibility is that targets of VIP may induce opposite effects on inflammation; VPAC2 activation on T cells shifts Th1 to Th2 differentiation as anti-inflammatory, whereas VPAC1 activation of epithelial cells increases anion and water secretion, with resultant diarrhea, which may affect the disease activity of colitis. The gene discussed is VIPR2; the disease is colitis.